Add BrightSurf on Google Email

Michigan Medicine - University of Michigan


Survey finds a need for pet care during hospitalizations

A survey conducted by Michigan Medicine found that nearly two-thirds of respondents experienced difficulty with pet care during hospitalization or knew someone who did. This stress can impact a patient's decision about staying in the hospital. Researchers aim to develop better resources and formalized services to address this need.

SourceMichigan Medicine - University of Michigan·JournalJournal of Patient Experience·TypeSurvey·DateOct 5, 2021

Medicaid expansion closed health gaps for low-income adults across racial and ethnic groups, study shows

A new study from the University of Michigan finds that Medicaid expansion in Michigan has significantly improved access to regular healthcare services for low-income adults across various racial and ethnic groups. By 2018, 83% of Healthy Michigan Plan enrollees reported having a regular doctor's office, with notable increases seen amon...

SourceMichigan Medicine - University of Michigan·JournalHealth Affairs·TypeSurvey·DateOct 4, 2021

When a free cancer check finds something, could cost keep patients from following up?

New studies show that patients with abnormal screening results may face significant out-of-pocket costs for follow-up tests, potentially delaying care. For women, colposcopy costs rose sharply over 13 years, with some facing bills of nearly $1,000. Lung cancer screening CT scans also led to high costs for invasive procedures.

SourceMichigan Medicine - University of Michigan·JournalObstetrics and Gynecology·TypeData/statistical analysis·DateOct 1, 2021

ECMO life support offers sickest COVID-19 patients a chance to survive, but a slimmer one than once thought

A new study found that the survival rate of COVID-19 patients on ECMO has decreased over time, with those treated later in the pandemic having lower chances of survival. Careful patient selection and resource management are essential for hospitals offering ECMO to maximize survival rates.

SourceMichigan Medicine - University of Michigan·JournalThe Lancet·TypeData/statistical analysis·DateSep 29, 2021

COVID-19 antibodies persist, reduce reinfection risk for up to six months, study finds

A Michigan Medicine study found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months. Nearly 90% of participants produced spike and nucleocapsid antibody responses, and all but one had persistent antibody levels at follow-up.

SourceMichigan Medicine - University of Michigan·JournalMicrobiology Spectrum·TypeObservational study·DateSep 14, 2021

Turning 65 means a lot for Americans’ wallets, health spending study finds

A new study suggests that lowering the age when older adults can enroll in Medicare might save them a significant amount of money. The study found that average out-of-pocket healthcare costs dropped by 27% for those turning 66, while nearly 9% of 64-year-olds were considered 'catastrophic' due to high health expenses.

SourceMichigan Medicine - University of Michigan·JournalJAMA Health Forum·TypeData/statistical analysis·DateSep 13, 2021

As dementia’s toll rises, new study shows major gaps in who gets care that could help them remain at home

A new study highlights significant disparities in dementia care availability by gender, race, ethnicity, education level, and family structure. The findings emphasize the importance of family caregivers, with those having available spouse or adult child support being less likely to move into nursing homes.

SourceMichigan Medicine - University of Michigan·JournalHealth Affairs·TypeObservational study·DateSep 8, 2021

Why do people with diabetes develop severe COVID-19?

A study from Michigan Medicine found that people with type 2 diabetes are more likely to develop a cytokine storm during coronavirus infection due to the enzyme SETDB2. Administering interferon beta increased SETDB2 and decreased inflammatory cytokines in diabetic mice, offering potential therapy for severe COVID-19.

SourceMichigan Medicine - University of Michigan·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateSep 7, 2021

Symptoms, like pain and fatigue, often cluster in newly diagnosed MS, study finds

A recent Michigan Medicine study found that people newly diagnosed with multiple sclerosis experience a myriad of significant symptoms that often cluster together. Nearly two-thirds of MS patients reported fatigue, half experienced pain in the first year after diagnosis. The research team collected questionnaires from MS patients at si...

SourceMichigan Medicine - University of Michigan·JournalMultiple Sclerosis Journal·TypeData/statistical analysis·DateAug 20, 2021

Existing drugs kill SARS-CoV2 in cells

Researchers have identified several drug contenders that can block or reduce SARS-CoV2 infection in cells, including lactoferrin and MEK-inhibitors. These findings suggest potential efficacy against COVID-19 variants, with ongoing clinical trials to examine their ability to reduce viral loads and inflammation.

SourceMichigan Medicine - University of Michigan·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateAug 19, 2021

Short hospitalizations hit hard for COVID patients

A US nationwide cohort study found that nearly 85% of hospitalized COVID-19 patients were not back to their pre-COVID lives one month later. The study also revealed significant factors driving people's inability to recover, including a lack of follow-up healthcare services and new disabilities preventing daily activities.

SourceMichigan Medicine - University of Michigan·JournalJournal of Hospital Medicine·TypeObservational study·DateAug 18, 2021

Pumping iron: Inhibition of key pathway promotes iron-dependent cell death in pancreatic cancer cells

Researchers have discovered that inhibiting the GOT1 enzyme can promote ferroptosis, a type of programmed cell death, in pancreatic cancer cells by conserving nutrients and releasing iron stores. This study provides a new potential therapeutic target for treating pancreatic cancer.

SourceMichigan Medicine - University of Michigan·JournalNature Communications·TypeExperimental study·DateAug 11, 2021

Potential biomarker found for lung disease in scleroderma patients

Researchers discovered a protein called CTRP9 associated with pulmonary function in scleroderma patients with interstitial lung disease. Patients with higher CTRP9 levels developed more severe lung disease, while low levels were linked to preserved function. The study suggests CTRP9 could help predict treatment needs for these patients.

SourceMichigan Medicine - University of Michigan·TypeData/statistical analysis·DateAug 3, 2021

Researchers uncover a way to harness the power of immunotherapy for advanced prostate cancer

Researchers have found a way to harness the power of immunotherapy for advanced prostate cancer by targeting a protein called PIKfyve. Blocking PIKfyve with the inhibitor ESK981 has been shown to increase tumor death and recruit immune T cells, offering new hope for patients with this challenging form of cancer.

SourceMichigan Medicine - University of Michigan·JournalNature Cancer·TypeExperimental study·DateAug 2, 2021

Study suggests need to screen older adults for mental health symptoms as pandemic continues

A new study suggests that older adults, particularly women and those in fair or poor health, are more likely to experience worsened mental health symptoms during the pandemic. The study recommends screening for depression, anxiety, and sleep problems and connecting participants to treatment resources.

SourceMichigan Medicine - University of Michigan·JournalJournal of General Internal Medicine·TypeSurvey·DateJul 28, 2021

Genomic test could help predict aggressive disease in men newly diagnosed with prostate cancer

A new genomic test may help identify patients at high risk of prostate cancer progression. The Decipher Biopsy test showed that men with high scores needed active treatment sooner, and those who underwent surgery had shorter time until PSA levels increased or they were put on anti-androgen therapy.

SourceMichigan Medicine - University of Michigan·JournalProstate Cancer and Prostatic Diseases·DateJul 27, 2021

Online mental health therapy significantly aids the isolated, immunosuppressed in pandemic

Researchers found that online mental health intervention improved anxiety and depression in people with scleroderma, a disease causing skin and connective tissue tightening. The four-week program offered group mental health intervention from trained peer support leaders, resulting in significant improvements six weeks later.

SourceMichigan Medicine - University of Michigan·JournalThe Lancet Rheumatology·DateJun 16, 2021